期刊文献+

对氧磷酶-1与代谢综合征的关系研究

Study on the relationship between paraoxonase-1(PON-1) and metabolic syndrome
下载PDF
导出
摘要 目的:探讨对氧磷酶-1(PON-1)与代谢综合征(MS)的关系。方法:本文测定31例MS患者和33例健康人血清PON-1活性,并应用聚合酶链式反应—限制性片段长度多态性(PCR-RFLP)技术研究其PON-1第191位密码子基因变异。结果:(1)MS组血清PON-1活性低于对照组,差别具有统计学意义(t=-3.6@P<0.05)。(2)MS组与对照组PON-1第191位密码子基因型分布无显著性差异(χ2=0.922@P>0.05)。结论:MS组血清PON-1活性显著低于对照组,这可能是MS患者心血管疾病高发的原因之一。 Objective: To reveal the relationship between serum PON-1 activity, PON-1 Q/R polymorphism and metabolic syndrome in Chinese Han ethnic group. Methods: The subjects of the study consisted of two groups: (1) metabolic syndrome group; (2) normal-control group. Serum PON-1 activity was determined using paraoxon as substrate by measuring the increase rate in the absorbance at 405 nm due to formation of 4-nitrophenol, and PON-1 Q/R polymorphism was evaluated by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Results: ( 1 ) There was no significant difference in the distribution of the PON-1 Q/R polymorphism between metabolic syndrome group and normal- control group (X^2=0.922, P〉0.05). (2) Serum PON-1 activity in metabolic syndrome group and normal- control group was (52.67±20.83)u/mland (74.85+-27.72)u/ml, respectively.SerumPON-1activityintheformer group was significantly low compared with the control group (t= -3.6, P 〈0.05). Conclusion: The present study suggested that serum PON-1 activity in metabolic syndrome group was significantly lower than fhe control group. Perhaps it was one of the reasons why MS patients were highly complicated with cardiovas- cular diseases.
出处 《天津医科大学学报》 2005年第3期362-364,共3页 Journal of Tianjin Medical University
基金 天津医科大学总医院院级课题(编号:1-17)
关键词 代谢综合征 对氧磷酶-1 血清对氧磷酶-1活性 基因多态性 Metabolic Syndrome PON-1 Serum PON-1 activity Polymorphism
  • 相关文献

参考文献8

  • 1Wastson AD, Berliner JA, La DU BN, et al. Protective effect of high density lipoprotein associated paraoxonase [J]. Journal Clinical Invest, 1995, 96(6):2 882.
  • 2Mackness MI, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familiar hypercholesterolaemia and insulin-dependent diabetes mellitus [J]. Atherosclerosis, 1991,86:193.
  • 3Humbert R, Alder DA, Disteche CM, et al. The molecular basis of the human serum paraoxonase activity polymorphism [J]. Nat Genet, 1993,3: 73.
  • 4Suehiro T,Nakamura T,Inoue M, et al. A polymorphism upstream from serum the human paraoxonase (PON1) gene and its association with PON 1 expression [J]. Atherosclerosis, 2000, 150(2):295.
  • 5James RW, Leviev I, Righetti A. Smoking is associated with reduced serum paraoxonase activity in patients with coronary artery disease [J]. Circulation, 2000,101(19):2 252.
  • 6Harangi M, Remenyik EE, Seres I, et al. Determination of DNA damage induced by oxidative stress in hyperlipidemiac patients [J].Mutat Res, 2002,513(1-2):17.
  • 7Mackness B, Mackness MI, Arrol S, et al. Serum paraoxonase(PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus [J].Atherosclerosis, 1998, 139:341.
  • 8Senti M, Tomas M, Fito M, et al. Antioxidant paraoxonase 1 activity in the metabolic syndrome [J]. J Clin Endocrinol Metab, 2003,88(11):5 422.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部